Trial Profile
LY2409021 Formulation Bridging and Food Effect Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Adomeglivant (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company (India) Pvt. Ltd
- 08 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Aug 2011 Planned end date changed from 1 Sep 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.